HRA Pharma Rare Diseases is providing an unrestricted educational grant to fund “Cushing’s Hub,” a first-of-its-kind online platform…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Although rare, Cushing’s disease associated with a tumor in the pituitary gland — a pea-size gland found deep within…
The cancer medicine bexarotene may hold promise for treating Cushing’s disease, a study suggests. The study, “Targeting…
Only about 10% of Cushing’s syndrome patients are children. Now, a rare case of the disease has been described in…
A young healthcare worker who contracted COVID-19 shortly after being diagnosed with Cushing’s disease was detailed in a…
SteroTherapeutics and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) are teaming…
People undergoing regular epidural steroid injections (ESIs) to ease back pain may be at increased risk of adrenal insufficiency,…
Two cases of Cushing’s syndrome that were diagnosed following pregnancy are described in a new report, which highlights the…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
Even slightly higher-than-normal levels of cortisol — the hormone that is abnormally high in people with Cushing’s syndrome…